Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes

Immunology Letters

Volumn 101, Issue 2, 2005, Pages 123-143

  Peeva, Elena ^a   Zouali, Moncef ^b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INSERM   (France)

^c CENTRE VIGGO PETERSEN   (France)

Author keywords

Androgen; B cell tolerance; B cells; Estrogen; Lupus; Negative selection; Prolactin

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; AUTOANTIGEN; BROMOCRIPTINE; CYCLOPHOSPHAMIDE; CYTOKINE; ENDOCRINE DISRUPTOR; ESTROGEN; FULVESTRANT; HORMONE; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; LY 139478; NAFOXIDINE; NANDROLONE DERIVATIVE; ORAL CONTRACEPTIVE AGENT; PRASTERONE; PROLACTIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL DEATH; CELL MATURATION; CELL SELECTION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFECT; ESTROGEN THERAPY; GLOMERULONEPHRITIS; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; NONHUMAN; OVARY INSUFFICIENCY; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; ENVIRONMENT; ESTROGENS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROLACTIN;

EID: 25444465654     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.05.014     Document Type: Review

References (260)

1. P. Schmid-Hempel Evolutionary ecology of insect immune defenses Annu Rev Entomol 50 2005 529 551
2. V. Morell Zeroing in on how hormones affect the immune system Science 269 1995 773 775
3. M. Zouali, and G. Sarmay B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment Arthritis Rheum 50 2004 2730 2741
4. E. Weinstein, E. Peeva, C. Putterman, and B. Diamond B-cell biology Rheum Dis Clin N Am 30 2004 159 174
5. M. Viau, and M. Zouali B-lymphocytes, innate immunity, and autoimmunity Clin Immunol 114 2005 17 26
6. D.P. Harris, L. Haynes, P.C. Sayles, D.K. Duso, S.M. Eaton, and N.M. Lepak Reciprocal regulation of polarized cytokine production by effector B and T cells Nat Immunol 1 2000 475 482
7. P.E. Lipsky Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity Nat Immunol 2 2001 764 766
8. M. Zouali Taming lupus Sci Am 292 2005 70 77
9. P. Beeson Age and sex associations of 40 autoimmune diseases Am J Med 96 1994 457 462
10. C. Mok, C.S. Lau, C.T. Ho, and R.W. Wong Do flares of systemic lupus erythematosus decline after menopause? Scand J Rheumatol 28 1999 357 362
11. C. Mok, R.W. Wong, and C.S. Lau Ovarian failure and flares of systemic lupus erythematosus Arthritis Rheum 42 1999 1274 1280
12. R. McMurray, D. Keisler, S. Izui, and S. Walker Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone Clin Immunol Immunopathol 71 1994 338 343
13. R. McMurray, D. Keisler, S. Izui, and S. Walker Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus J Rheumatol 20 1993 1143 1151
14. J. Roubinian, N. Talal, P.K. Siiteri, and J.A. Sadakian Sex hormone modulation of autoimmunity in NZB/NZW mice Arthritis Rheum 22 1979 1162 1169
15. J. Roubinian, N. Talal, J. Greenspan, J. Goodman, and P. Siiteri Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice J Exp Med 147 1978 1568 1583
16. F. Melchers, E. ten Boekel, T. Seidl, X.C. Kong, T. Yamagami, and K. Onishi Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells Immunol Rev 175 2000 33 46
17. M.Z. Radic, and M. Zouali Receptor editing, immune diversification, and self-tolerance Immunity 5 1996 505 511
18. D. Nemazee, and M. Weigert Revising B cell receptors J Exp Med 191 2000 1813 1817
19. T. Su, B. Guo, B. Wei, J. Braun, and D.J. Rawlings Signaling in transitional type 2 B cells is critical for peripheral B-cell development Immunol Rev 197 2004 161 178
20. D. Allman, R.C. Lindsley, W. DeMuth, K. Rudd, S.A. Shinton, and R.R. Hardy Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation J Immunol 167 2001 6834 6840
21. J. Chung, R.A. Sater, M.L. Fields, J. Erikson, and J.G. Monroe CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals Int Immunol 14 2002 157 166
22. T. Su, and D. Rawlings Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development J Immunol 168 2002 2101 2110
23. K. Ansel, and J.G. Cyster Chemokines in lymphopoiesis and lymphoid organ development Curr Opin Immunol 13 2001 172 179
24. M. Batten, J. Groom, T.G. Cachero, F. Qian, P. Schneider, and J. Tschopp BAFF mediates survival of peripheral immature B lymphocytes J Exp Med 192 2000 1453 1466
25. B. Schiemann, J.L. Gommerman, K. Vora, T.G. Cachero, S. Shulga-Morskaya, and M. Dobles An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway Science 293 2001 2111 2114
26. F. Martin, and J.F. Kearney B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory" Immunol Rev 175 2000 70 79
27. T.K.J. Lopes-Carvalho Marginal zone B cell physiology and disease Curr Dir Autoimmun 8 2005 91 123
28. C. Demaison, P. Chastagner, J. Theze, and M. Zouali Somatic diversification in the heavy chain variable region genes expressed by human autoantibodies bearing a lupus-associated nephritogenic anti-DNA idiotype Proc Natl Acad Sci USA 91 1994 514 518
29. M.Z. Radic, and M. Weigert Genetic and structural evidence for antigen selection of anti-DNA antibodies Annu Rev Immunol 12 1994 487 520
30. X. Chen, F. Martin, K.A. Forbush, R.M. Perlmutter, and J.F. Kearney Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone Int Immunol 9 1997 27 41
31. J. Kenny, L.J. Rezanka, A. Lustig, R.T. Fischer, J. Yoder, and S. Marshall Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors J Immunol 164 2000 4111 4119
32. Y. Li, H. Li, D. Ni, and M. Weigert Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern J Exp Med 196 2002 1543 1552
33. R. Brummel, and P. Lenert Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides J Immunol 174 2005 2429 2434
34. J. Wither, A. Paterson, and B. Vukusic Genetic dissection of B cell traits in New Zealand black mice. The expanded population of B cells expressing up-regulated costimulatory molecules shows linkage to Nba2 Eur J Immunol 30 2000 356 365
35. R. Jonsson, K.A. Brokstad, P.E. Lipsky, and M. Zouali B-lymphocyte selection and autoimmunity Trends Immunol 22 2001 653 654
36. S.K. Datta, and S.L. Kalled CD40-CD40 ligand interaction in autoimmune disease Arthritis Rheum 40 1997 1735 1745
37. R. Looney, J. Anolik, and I. Sanz B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells Lupus 13 2004 381 390
38. F. Arnalich, S. Benito-Urbina, P. Gonzalez-Gancedo, E. Iglesias, E. de Miguel, and J. Gijon-Banos Inadequate production of progesterone in women with systemic lupus erythematosus Br J Rheumatol 31 1992 247 251
39. I. Chikanza Prolactin and neuroimmunomodulation: in vitro and in vivo observations Ann NY Acad Sci 876 1999 119 130
40. M. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: structure, function, and regulation of secretion Physiol Rev 80 2000 1523 1631
41. M. Lorenson In vitro conditions modify immunoassayability of bovine pituitary prolactin and growth hormone: insights into their secretory granule storage forms Endocrinology 116 1985 1399 1407
42. M. Lorenson, and L.S. Jacobs Thiol regulation of protein, growth hormone, and prolactin release from isolated adenohypophysial secretory granules Endocrinology 110 1982 1164 1172
43. L.S. Haro, D.W. Lee, R.N. Singh, G. Bee, E. Markoff, and U.J. Lewis Glycosylated human prolactin: alterations in glycosylation pattern modify affinity for lactogen receptor and values in prolactin radioimmunoassay J Clin Endocrinol Metab 71 1990 379 383
44. A. Leanos-Miranda, K. Chavez-Rueda, and F. Blanco-Favela Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus Arthritis Rheum 44 2001 866 875
45. C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P.A. Kelly Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice Endocr Rev 19 1998 225 258
46. D. Weigent Immunoregulatory properties of growth Pharmacol Ther 69 1996 237 257
47. P. Kelly, S. Ali, M. Rozakis, L. Goujon, M. Nagano, and I. Pellegrini The growth hormone/prolactin receptor family Recent Prog Horm Res 48 1993 123 164
48. P. Kelly, J. Dijane, and M. Edery Different forms of the prolactin receptor: insights into the mechanisms of prolactin action Trends Endocrinol Metab 3 1992 54 59
49. J.B. Kline, H. Roehrs, and C.V. Clevenger Functional characterization of the intermediate isoform of the human prolactin receptor J Biol Chem 274 1999 35461 35468
50. J.B. Kline, D.J. Moore, and C.V. Clevenger Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site Mol Endocrinol 15 2001 832 841
51. J. Boutin Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells Mol Endocrinol 3 1989 1455 1461
52. C. Clevenger, W. Ngo, D. Sokol, S. Luger, and A. Gewirtz Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line Am J Pathol 146 1995 1 11
53. M. Nagano Expression of prolactin and growth hormone recptor genes and their isoforms in the gastrointesinal tract Am J Phys 268 1995 G431 G442
54. C. Clevenger, and J. Kline Prolactin receptor signal transduction Lupus 10 2001 706 718
55. L. Yu-Lee Stimulation of interferon regulatory factor-1 by prolactin Lupus 10 2001 691 699
56. L. Yu-Lee Molecular actions of prolactin on the immune system Proc Soc Exp Biol Med 215 1997 35 52
57. P. Mukherjee, A. Mastro, and W. Hymer Prolactin induction of interleukin-2 on rat splenic lymphocytes Endocrinology 26 1990 88 94
58. R. Hooghe, Z. Dogusan, N. Martens, B. Velkeniers, and E. Hooghe-Peters Effects of prolactin on signal transduction and gene expression: possible relevance for systemic lupus erythematosus Lupus 10 2001 719 727
59. K. Dorshkind, and N. Horseman Anterior pituitary hormones, stress, and immune system homeostasis Bioessays 23 2001 288 294
60. S. Walker, R. McMurray, J. Houri, S. Allen, D. Keisler, and G. Sharp Effects of prolactin in stimulating disease activity in systemic lupus erythematosus Ann NY Acad Sci 840 1998 762 772
61. R. Mc Murray Estrogen, prolactin, and autoimmunity: actions and interactions Int Immunopharmacol 1 2001 995 1008
62. E. Peeva, J. Venkatesh, D. Michael, and B. Diamond Prolactin as a modulator of B cell function: implications for SLE Biomed Pharmacother 58 2004 310 319
63. L. Matera, M. Cutufia, M. Geuna, M. Contarini, S. Buttiglieri, and S. Galin Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line J Neuroimmunol 79 1997 12 21
64. D.W. Montgomery, G.K. Shen, E.D. Ulrich, L.L. Steiner, P.R. Parrish, and C.F. Zukoski Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins Endocrinology 131 1992 3019 3026
65. Y. Sinha Structural variants of prolactin: occurrence and physiological significance Endocr Rev 16 1995 354 369
66. M. Leite De Moraes, P. Touraine, M. Gagnerault, W. Savino, P. Kelly, and M. Dardenne Prolactin receptors and the immune system Ann Endocrinol (Paris) 56 1995 567 570
67. N.D. Horseman, W. Zhao, E. Montecino-Rodriguez, M. Tanaka, K. Nakashima, and S.J. Engle Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene EMBO J 16 1997 6926 6935
68. B. Bouchard, C. Ormandy, J. Di Santo, and P. Kelly Immune system development and function in prolactin receptor-deficient mice J Immunol 163 1999 576 582
69. + human hematopoietic progenitor cells J Cell Physiol 163 1995 221 231
70. J. Moreno, A. Varas, A. Vicente, and A. Zapata Role of prolactin in the recovered T-cell development of early partially decapitated chicken embryo Dev Immunol 5 1998 183 195
71. P. Morales, M. Carretero, H. Geronimo, S. Copin, M. Gaspar, and M. Marcos Influence of prolactin on the differentiation of mouse B -lymphoid precursors Cell Growth Differ 10 1999 583 590
72. T. Giglio, M.A. Imro, G. Filaci, M. Scudeletti, F. Puppo, and L. De Cecco Immune cell circulating subsets are affected by gonadal function Life Sci 54 1994 1305 1312
73. E. Peeva, D. Michael, J. Cleary, J. Rice, X. Chen, and B. Diamond Prolactin modulates the naive B cell repertoire J Clin Invest 111 2003 275 283
74. F. Loder, B. Mutschler, R. Ray, C. Paige, P. Sideras, and R. Torres B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals J Exp Med 190 1999 75 89
75. J. Krumenacker, D. Buckley, M. Leff, J. McCormack, G. de Jong, and P. Gout Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression Endocrine 9 1998 163 170
76. A. Buckley Prolactin, lymphocyte growth and survival factor Lupus 10 2001 684 690
77. A. Buckley, D. Buckley, M. Leff, D. Hoover, and N. Magnuson Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells Endocrinology 136 1995 5252 5259
78. S. Kochendoerfer, N. Krishnan, D. Buckley, and A. Buckley Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells J Endocrinol 178 2003 265 273
79. K. Gado, E. Pallinger, P. Kovacs, E. Takacs, I. Szilvasi, and B. Toth Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266 Immunol Lett 82 2002 191 196
80. B. Athreya, J. Pletcher, F. Zulian, D.B. Weiner, and W.V. Williams Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro Clin Immunol Immunopathol 66 1993 201 211
81. A. Cesano, E. Oberholtzer, M. Contarini, M. Geuna, G. Bellone, and L. Matera Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors Immunopharmacology 28 1994 67 75
82. T. Cesario, S. Yousefi, G. Carandang, N. Sadati, J. Le, and N. Vaziri Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells Proc Soc Exp Biol Med 205 1994 89 95
83. C. Sandi, J. Cambronero, J. Borrell, and C. Guaza Mutually antagonistic effects of corticosterone and prolactin on rat lymphocyte proliferation Neuroendocrinology 56 1992 574 581
84. P. Sabharwal, R. Glaser, W. Lafuse, S. Varma, Q. Liu, and S. Arkins Prolactin synthetized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation Proc Natl Acad Sci USA 89 1992 7713 7716
85. D. Hartmann, J. Holaday, and E. Bernton Inhibition of lymphocyte proliferation by antibodies to prolactin FASEB J 3 1989 2194 2202
86. S. Richards, R.D. Garman, L. Keyes, B. Kavanagh, and J.M. McPherson Prolactin is an antagonist of TGF-beta activity and promotes proliferation of murine B cell hybridomas Cell Immunol 184 1998 85 91
87. P.E. Walton, and M.J. Cronin Tumor necrosis factor-alpha and interferon-gamma reduce prolactin release in vitro Am J Physiol 259 1990 E672 E676
88. K. Koike, N. Masumoto, K. Kasahara, M. Yamaguchi, K. Tasaka, and K. Hirota Tumor necrosis factor-alpha stimulates prolactin release from anterior pituitary cells: a possible involvement of intracellular calcium mobilization Endocrinology 128 1991 2785 2790
89. S. Theas, D. Pisera, B. Duvilanski, A. De Laurentiis, M. Pampillo, and M. Lasaga Estrogens modulate the inhibitory effect of tumor necrosis factor-alpha on anterior pituitary cell proliferation and prolactin release Endocrine 12 2000 249 255
90. B. Majumder, R. Biswas, and U. Chattopadhyay Prolactin regulates antitumor immune response through induction of tumoricidal macrophages and release of IL-12 Int J Cancer 97 2002 493 500
91. L. Matera, A. Galetto, M. Geuna, K. Vekemans, E. Ricotti, and M. Contarini Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions Immunology 100 2000 29 36
92. L. Matera, and M. Mori Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells Ann NY Acad Sci 917 2000 505 513
93. A. Kumar, S. Singh, and A. Sodhi Effect of prolactin on nitric oxide and interleukin-1 production of murine peritoneal macrophages: role of Ca2+ and protein kinase C Int J Immunopharmacol 19 1997 129 133
94. Y. Tseng, M.A. Kessler, and L.A. Schuler Regulation of interleukin (IL)-1alpha, IL-1beta, and IL-6 expression by growth hormone and prolactin in bovine thymic stromal cells Mol Cell Endocrinol 1 128 1997 117 127
95. A. Khoruts, R.E. Osness, and M.K. Jenkins IL-1 acts on antigen-presenting cells to enhance the in vivo proliferation of antigen-stimulated naive CD4 T cells via a CD28-dependent mechanism that does not involve increased expression of CD28 ligands Eur J Immunol 34 2004 1085 1090
96. G. Jego, V. Pascual, A. Palucka, and J. Banchereau Dendritic cells control B cell growth and differentiation Curr Dir Autoimmun 8 2005 124 139
97. L. Matera, M. Mori, and A. Galetto Effect of prolactin on antigen presenting function of monocyte derived dendritic cells Lupus 10 2001 728 734
98. Y. Liu, J.A. Cairns, M.J. Holder, S.D. Abbot, K.U. Jansen, and J.Y. Bonnefoy Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis Eur J Immunol 21 1991 1107 1114
99. L. Granziero, P. Ghia, P. Circosta, D. Gottardi, G. Strola, and M. Geuna Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia Blood 97 2001 2777 2783
100. H. Hirai, T. Adachi, and T. Tsubata Involvement of cell cycle progression in survival signaling through CD40 in the B-lymphocyte line WEHI-231 Cell Death Differ 11 2004 261 269
101. N. Lahat, A. Miller, R. Shtiller, and E. Touby Differential effects of prolactin upon activation and differentiation of human B lymphocytes J Neuroimmunol 47 1993 35 40
102. E. Nagy, I. Berczi, and H.G. Friesen Regulation of immunity in rats by lactogenic and growth hormones Acta Endocrinol (Copenh) 102 1983 351 357
103. E. Nagy, I. Berczi, G. Wren, S. Asa, and K. Kovacs Immunomodulation by bromocriptine Immunopharmacology 6 1983 231 243
104. I. Krause, Z. Blumenfeld, M. Malchinsky, S. Cohen, M. Blank, and A. Eldor Anti-endothelial cell antibodies in the sera of hyperprolactinemic women Lupus 7 1998 377 382
105. L. Jara, C. Lavalle, A. Fraga, C. Gomez-Sanchez, L.H. Silveira, and P. Martinez-Osuna Prolactin, immunoregulation, and autoimmune diseases Semin Arthritis Rheum 20 1991 273 284
106. D. Kozakova, J. Rovensky, L. Cebecauer, V. Bosak, E. Jahnova, and M. Vigas Prolactin levels and autoantibodies in female patients with systemic lupus erythematosus Z Rheumatol 59 Suppl. 2 2000 80 84
107. S.E. Walker, R.W. McMurray, C.L. Besch-Williford, and D.H. Keisler Premature death with bladder outlet obstruction and hyperprolactinemia in New Zealand black X New Zealand white mice treated with ethinyl estradiol and 17 beta-estradiol Arthritis Rheum 35 1992 1387 1392
108. R.W. McMurray, S.H. Allen, A.L. Braun, F. Rodriguez, and S.E. Walker Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease J Rheumatol 21 1994 843 850
109. R. McMurray, D. Keisler, K. Kanuckel, S. Izui, and S. Walker Prolactin influences autoimmune disease activity in the female NZB/W mouse J Immunol 147 1991 3780 3787
110. K. Elbourne, D. Keisler, and R. McMurray Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus Lupus 7 1998 420 427
111. M. Blank, I. Krause, D. Buskila, D. Teitelbaum, J. Kopolovic, and A. Afek Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells Cell Immunol 162 1995 114 122
112. D. Offen, L. Spatz, H. Escowitz, S. Factor, and B. Diamond Induction of tolerance to an IgG autoantibody Proc Natl Acad Sci USA 89 1992 8332 8336
113. C.M. Grimaldi, J. Cleary, A.S. Dagtas, D. Moussai, and B. Diamond Estrogen alters thresholds for B cell apoptosis and activation J Clin Invest 109 2002 1625 1633
114. S. Walker, and J.D. Jacobson Roles of prolactin and gonadotropin- releasing hormone in rheumatic diseases Rheum Dis Clin N Am 26 2000 713 736
115. R. Blackwell Hyperprolactinemia. Evaluation and management Endocrinol Metab Clin N Am 21 1992 105 124
116. M. Funauchi, S. Ikoma, H. Enomoto, M. Sugiyama, M. Ohno, and K. Hamada Prolactin modulates disease activity of systemic lupus erytheamtosus accompanied by prolactinoma Clin Exp Rheumatol 16 1998 479 482
117. M.A. Gutierrez, J.F. Molina, L.J. Jara, M.L. Cuellar, C. Garcia, and S. Gutierrez-Urena Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity Lupus 4 1995 348 352
118. R. Chan, L.S. Tam, E.K. Li, F.M. Lai, K.M. Chow, and K.B. Lai Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis Arthritis Rheum 48 2003 1326 1331
119. M. Tomita, B.J. Holman, L.S. Williams, K.C. Pang, and T.J. Santoro Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus J Neurosci Res 64 2001 26 33
120. K. Miyai, K. Ichihara, K. Kondo, and S. Mori Asymptomatic hyperprolactinaemia and prolactinoma in the general population - mass screening by paired assays of serum prolactin Clin Endocrinol (Oxford) 25 1986 549 554
121. J.M. Miranda, R.E. Prieto, R. Paniagua, G. Garsia, D. Amato, and L. Barile Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis Lupus 7 1998 387 391
122. J. Munoz, A. Gil, J.M. Lopez-Dupla, J.J. Vazquez, and P. Gonzalez-Gancedo Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters Ann Med Intern (Paris) 145 1994 459 463
123. L. Moszkorzova, Z. Lacinova, J. Marek, L. Musilova, A. Dohnalova, and C. Dostal Hyperprolactinaemia in patients with systemic lupus erythematosus Clin Exp Rheumatol 20 2002 807 812
124. R.W. McMurray, S.H. Allen, P.H. Pepmueller, D. Keisler, and J.T. Cassidy Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity J Rheumatol 22 1995 1577 1580
125. M. Pacilio, S. Migliaresi, R. Meli, L. Ambrosone, B. Bigliardo, and R. Di Carlo Elevated bioactive prolactin levels in systemic lupus erythematosus - association with disease activity J Rheumatol 28 2001 2216 2221
126. O. Vera-Lastra, C. Mendez, L. Jara, M. Cisneros, G. Medina, and R. Ariza Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment J Rheumatol 30 2003 2140 2146
127. A. El-Garf, S. Salah, M. Shaarawy, S. Zaki, and S. Anwer Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestations J Rheumatol 23 1996 374 377
128. A. Leanos-Miranda, D. Pascoe-Lira, K. Chavez-Rueda, and F. Blanco-Favela Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity J Rheumatol 28 2001 1546 1553
129. P. Brennan, A. Hajeer, K.R. Ong, J. Worthington, S. John, and W. Thomson Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus Arthritis Rheum 40 1997 1383 1386
130. A. Stevens, D. Ray, J. Worthington, and J. Davis Polymorphisms of the human prolactin gene - implications for production of lymphocyte prolactin and systemic lupus erythematosus Lupus 10 2001 676 683
131. M. Mellai, M. Giordano, S. D'Alfonso, M. Marchini, R. Scorza, and M. Giovanna Danieli Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus Hum Immunol 64 2003 274 284
132. C. Watson, A.M. Norfleet, T.C. Pappas, and B. Gametchu Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-alpha Steroids 64 1990 5 13
133. T. Pappas, B. Gametchu, and C.S. Watson Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding FASEB J 9 1995 404 410
134. E. Levin Cellular functions of the plasma membrane estrogen receptor Trends Endocrinol Metab 10 1999 374 377
135. W. Benten, C. Stephan, M. Lieberherr, and F. Wunderlich Estradiol signaling via sequestrable surface receptors Endocrinology 142 2001 1669 1677
136. J. Weusten, M.A. Blankenstein, F.H. Gmelig-Meyling, H.J. Schuurman, L. Kater, and J.H. Thijssen Presence of oestrogen receptors in human blood mononuclear cells and thymocytes Acta Endocrinol (Copenh) 112 1986 409 414
137. J. Tornwall, A.B. Carey, R.I. Fox, and H.S. Fox Estrogen in autoimmunity: expression of estrogen receptors in thymic and autoimmune T cells J Gend Specif Med 2 1999 33 40
138. R. Suenaga, M.J. Evans, K. Mitamura, V. Rider, and N.I. Abdou Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells J Rheumatol 25 1998 1305 1312
139. M. Nilsson, K. Dahlman-Wright, and J.A. Gustafsson Nuclear receptors in disease: the oestrogen receptors Essays Biochem 40 2004 157 167
140. L. McCauley, T.F. Tozum, and T.J. Rosol Estrogen receptors in skeletal metabolism: lessons from genetically modified models of receptor function Crit Rev Eukaryot Gene Expr 12 2002 89 100
141. J.M. Emmen, and K.S. Korach Estrogen receptor knockout mice: phenotypes in the female reproductive tract Gynecol Endocrinol 17 2003 169 176
142. J. Couse, and K. Korach Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20 1999 358 417
143. B. McEwen, and S.E. Alves Estrogen actions in the central nervous system Endocrine Rev 20 1999 279 307
144. M. Sluyser Hormone resistance in cancer: the role of abnormal steroid receptors Crit Rev Oncog 5 1994 539 554
145. S.M. Cowley, S. Hoare, S. Mosselman, and M.G. Parker Estrogen receptors alpha and beta form heterodimers on DNA J Biol Chem 272 1997 19858 19862
146. K. Pettersson, K. Grandien, G.G. Kuiper, and J.A. Gustafsson Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha Mol Endocrinol 11 1997 1486 1496
147. Y.L. Wu, X. Yang, Z. Ren, D.P. McDonnell, J.D. Norris, and T.M. Willson Structural Basis for an Unexpected Mode of SERM-Mediated ER Antagonism Mol Cell 18 2005 413 424
148. K. Medina, G. Smithson, and P.W. Kincade Suppression of B lymphopoiesis during normal pregnancy J Exp Med 178 1993 1507 1515
149. G. Smithson, W.G. Beamer, K.L. Shultz, S.W. Christianson, L.D. Shultz, and P.W. Kincade Increased B lymphopoiesis in genetically sex steroid-deficient hypogonadal (hpg) mice J Exp Med 180 1994 717 720
150. K. Medina, and P.W. Kincade Pregnancy-related steroids are potential negative regulators of B lymphopoiesis Proc Natl Acad Sci USA 91 1994 5382 5386
151. A.G. Rijhsinghani, K. Thompson, S.K. Bhatia, and T.J. Waldschmidt Estrogen blocks early T cell development in the thymus Am J Reprod Immunol 36 1996 269 277
152. H. Carlsten, R. Holmdahl, A. Tarkowski, and L.A. Nilsson Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits Immunology 68 1989 209 214
153. H. Carlsten, R. Holmdahl, A. Tarkowski, and L.A. Nilsson Oestradiol suppression of delayed-type hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain Immunology 67 1989 205 209
154. E. Josefsson, A. Tarkowski, and H. Carlsten Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils Cell Immunol 142 1992 67 78
155. N. Hanna, and M. Schneider Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment J Immunol 130 1983 974 980
156. N. Nilsson, and H. Carlsten Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation Cell Immunol 158 1994 131 139
157. Y. Ishimi, C. Miyaura, M. Ohmura, Y. Onoe, T. Sato, and Y. Uchiyama Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency Endocrinology 140 1999 1893 1900
158. G. Smithson, J.F. Couse, D.B. Lubahn, K.S. Korach, and P.W. Kincade The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis J Immunol 161 1998 27 34
159. J. Staples, T.A. Gasiewicz, N.C. Fiore, D.B. Lubahn, K.S. Korach, and A.E. Silverstone Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations. J Immunol 163 1999 4168 4174
160. T.S. Thurmond, F.G. Murante, J.E. Staples, A.E. Silverstone, K.S. Korach, and T.A. Gasiewicz Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse Endocrinology 141 2000 2309 2318
161. K.L. Medina, K.P. Garrett, L.F. Thompson, M.I. Rossi, K.J. Payne, and P.W. Kincade Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen Nat Immunol 2 2001 718 724
162. M.C. Erlandsson, C.A. Jonsson, U. Islander, C. Ohlsson, and H. Carlsten Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice Immunology 108 2003 346 351
163. H. Igarashi, T. Kouro, T. Yokota, P.C. Comp, and P.W. Kincade Age and stage dependency of estrogen receptor expression by lymphocyte precursors Proc Natl Acad Sci USA 98 2001 15131 15136
164. P. Kincade, K.L. Medina, K.J. Payne, M.I. Rossi, K.S. Tudor, and Y. Yamashita Early B-lymphocyte precursors and their regulation by sex steroids Immunol Rev 175 2000 128 137
165. C. Grimaldi, D. Michael, and B. Diamond Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus J Immunol 167 2001 1886 1890
166. K. Medina, A. Strasser, and P.W. Kincade Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors Blood 95 2000 2059 2067
167. L. Hoffman-Goetz Effect of estradiol and exercise on lymphocyte proliferation responses in female mice Physiol Behav 68 1999 169 174
168. N. Kanda, and K. Tamaki Estrogen enhances immunoglobulin production by human PBMCs J Allergy Clin Immunol 103 1999 282 288
169. N.Sa.P. Golstein The Fas death factor Science 267 1995 1449 1456
170. G. Mor, F. Kohen, J. Garcia-Velasco, J. Nilsen, W. Brown, and J. Song Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen J Steroid Biochem Mol Biol 73 2000 185 194
171. B. Perillo, A. Sasso, C. Abbondanza, and G. Palumbo 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence Mol Cell Biol 20 2000 2890 2901
172. R. Hill, S. Pompolo, M.E. Jones, E.R. Simpson, and W.C. Boon Estrogen deficiency leads to apoptosis in dopaminergic neurons in the medial preoptic area and arcuate nucleus of male mice Mol Cell Neurosci 27 2004 466 476
173. D. Mishra, and C. Shaha Estrogen-induced spermatogenic cell apoptosis occurs via the mitochondrial pathway: role of superoxide and nitric oxide Biol Chem 280 2005 6181 6196
174. J. Song, T. Rutherford, F. Naftolin, S. Brown, and G. Mor Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells Mol Hum Reprod 8 2002 447 455
175. J. Nilsen, G. Mor, and F. Naftolin Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system J Neurobiol 43 2000 64 78
176. G. Yao, and Y. Hou Thymic atrophy via estrogen-induced apoptosis is related to Fas/FasL pathway Int Immunopharmacol 4 2004 213 221
177. G. Mor, A. Munoz, R. Redlinger Jr., I. Silva, J. Song, and C. Lim The role of the Fas/Fas ligand system in estrogen-induced thymic alteration Am J Reprod Immunol 46 2001 298 307
178. + Th2 cells by altering Bcl 2 expression Lupus 8 1999 384 387
179. N. Kanda, and S. Watanabe 17beta-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression J Invest Dermatol 121 2003 1500 1509
180. L. Garcia-Segura, P. Cardona-Gomez, F. Naftolin, and J.A. Chowen
181. J.C. Sabourin, A. Martin, J. Baruch, J.B. Truc, A. Gompel, and P. Poitout Bcl-2 expression in normal breast tissue during the menstrual cycle Int J Cancer 59 1994 1 6
182. A. Gompel, J.C. Sabourin, A. Martin, H. Yaneva, J. Audouin, and Y. Decroix Bcl-2 expression in normal endometrium during the menstrual cycle Am J Pathol 144 1994 1195 1202
183. Y. Huang, S. Ray, J.C. Reed, A.M. Ibrado, C. Tang, and A. Nawabi Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells Breast Cancer Res Treat 42 1997 73 81
184. J. Jenkins, S. Suwannaroj, K.B. Elbourne, K. Ndebele, and R.W. McMurray 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A Int Immunopharmacol 1 2001 1897 1911
185. R. McMurray, S. Suwannaroj, K. Ndebele, and J.K. Jenkins Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels Pathobiology 69 2001 44 58
186. M. Bynoe, C. Grimaldi, and B. Diamond Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells Proc Natl Acad Sci USA 97 2000 2703 2708
187. M. Evans, K. Lai, L.J. Shaw, D.C. Harnish, and C.C. Chadwick Estrogen receptor alpha inhibits IL-1beta induction of gene expression in the mouse liver Endocrinology 143 2002 2559 2570
188. M. Salem Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production Curr Drug Targets Inflamm Allergy 3 2004 97 104
189. H. Liu, A.C. Buenafe, A. Matejuk, A. Ito, A. Zamora, and J. Dwyer Estrogen inhibition of EAE involves effects on dendritic cell function J Neurosci Res 70 2002 238 248
190. E. Giltay, J.C. Fonk, B.M. von Blomberg, H.A. Drexhage, C. Schalkwijk, and L.J. Gooren In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans J Clin Endocrinol Metab 85 2000 1648 1657
191. M. Kamada, M. Irahara, M. Maegawa, Y. Ohmoto, K. Murata, and T. Yasui Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy Gynecol Obstet Invest 52 2001 82 88
192. A. Akoum, A. Lemay, and R. Maheux Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells J Clin Endocrinol Metab 87 2002 5785 5792
193. V. Paharkova-Vatchkova, R. Maldonado, and S. Kovats Estrogen preferentially promotes the differentiation of CD11c+ CD11b (intermediate) dendritic cells from bone marrow precursors J Immunol 172 2004 1426 1436
194. M. Butterworth, B. McClellan, and M. Allansmith Influence of sex in immunoglobulin levels Nature 214 1967 1224 1225
195. V. Rider, S. Jones, M. Evans, H. Bassiri, Z. Afsar, and N.I. Abdou Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus J Rheumatol 28 2001 2644 2649
196. S. Ansar Ahmed, M.J. Dauphinee, A.I. Montoya, and N. Talal Estrogen induces normal murine CD5+ B cells to produce autoantibodies J Immunol 142 1989 2647 2653
197. J. Brick, S.H. Ong, J.M. Bathon, S.E. Walker, F.X. O'Sullivan, and A.G. DiBartolomeo Anti-histone antibodies in the serum of autoimmune MRL and NZB/NZW1 F1 mice Clin Immunol Immunopathol 54 1990 372 381
198. A. Steinberg, K.A. Melez, E.S. Raveche, J.P. Reeves, W.A. Boegel, and P.A. Smathers Approach to the study of the role of sex hormones in autoimmunity Arthritis Rheum 22 1979 1170 1176
199. M. Duvic, A.D. Steinberg, and L.W. Klassen Effect of the anti-estrogen, nafoxidine, on NZB/W autoimmune disease Arthritis Rheum 21 1978 414 417
200. W. Wu, B. Lin, Y. Su, J. Suen, and B. Chiang Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice Scand J Immunol 52 2000 393 400
201. L.D. Apelgren, D.L. Bailey, R.L. Fouts, L. Short, N. Bryan, and G.F. Evans The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice Cell Immunol 173 1996 55 63
202. B.D. Greenstein, Y.Y. Dhaher, F. Bridges Ede, G. Keser, M.A. Khamashta, and J. Etherington Effects of an aromatase inhibitor on thymus and kidney and on oestrogen receptors in female MRL/MP-lpr/lpr mice Lupus 2 1993 221 225
203. B. Athreya, W.C. Moore, S.A. Wadsworth, C. Gupta, and A.S. Goldman Estrogen receptor levels in a murine model of systemic lupus erythematosus Clin Exp Rheumatol 7 1989 589 593
204. Y. Dhaher, B. Greenstein, E. de Fougerolles Nunn, M. Khamashta, and G.R. Hughes Strain differences in binding properties of estrogen receptors in immature and adult BALB/c and MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus Int J Immunopharmacol 22 2000 247 254
205. R. Roa, and B.D. Greenstein Evidence for pleomorphism of estrogen receptor capacity and affinity in liver and thymus of immature BALB/c and (NZB × NZW) F1 mice, a model of systemic lupus erythematosus Int J Immunopharmacol 22 2000 897 903
206. G.J. Shim, L.L. Kis, M. Warner, and J.A. Gustafsson Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene Proc Natl Acad Sci USA 101 2004 1720 1724
207. D. Verthelyi, and S.A. Ahmed Estrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 mice Cell Immunol 189 1998 125 134
208. D. Verthelyi, and S.A. Ahmed 17 beta-estradiol, but not 5 alpha-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice Endocrinology 135 1994 2615 2622
209. M. Bynoe, L. Spatz, and B. Diamond Characterization of anti-DNA B cells that escape negative selection Eur J Immunol 29 1999 1304 1313
210. P. Kuo, M. Bynoe, C. Wang, and B. Diamond Bcl-2 leads to expression of anti-DNA B cells but no nephrits: a model for clinical subset Eur J Immunol 29 1999 3168 3178
211. L. Spatz, V. Saenko, A. Iliev, L. Jones, L. Geskin, and B. Diamond Light chain usage in anti-dsDNA B cell subsets: role in cell fate determination J Exp Med 185 1997 1317 1326
212. S. Pillai, A. Cariappa, and S.T. Moran Positive selection and lineage commitment during peripheral B-lymphocyte development Immunol Rev 197 2004 206 218
213. N. Ishimaru, K. Saegusa, K. Yanagi, N. Haneji, I. Saito, and Y. Hayashi Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through fas-mediated apoptosis Am J Pathol 155 1999 173 181
214. R.G. Lahita, H.L. Bradlow, H.G. Kunkel, and J. Fishman Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus J Clin Endocrinol Metab 53 1981 174 178
215. R. Lahita, H.L. Bradlow, H.G. Kunkel, and J. Fishman Alterations of estrogen metabolism in systemic lupus erythematosus Arthritis Rheum 22 1979 1195 1198
216. R. Kelly, and F.T. Vertosick Jr. Systemic lupus erythematosus: a role for anti-receptor antibodies? Med Hypotheses 20 1986 95 101
217. L. Westberg, H.P. Ho, F. Baghaei, S. Nilsson, J. Melke, and R. Rosmond Polymorphisms in oestrogen and progesterone receptor genes: possible influence on prolactin levels in women Clin Endocrinol (Oxford) 61 (August) 2 2004 216 223
218. Z.H. Liu, Z.H. Cheng, R.J. Gong, H. Liu, D. Liu, and L.S. Li Sex differences in estrogen receptor gene polymorphism and its association with lupus nephritis in Chinese Nephron 90 2002 174 180
219. N. Kanda, T. Tsuchida, and K. Tamaki Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus Arthritis Rheum 42 1999 328 337
220. A. Desai-Mehta, L. Lu, R. Ramsey-Goldman, and S.K. Datta Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production J Clin Invest 97 1996 2063 2073
221. H. Nagafuchi, Y. Shimoyama, J. Kashiwakura, M. Takeno, T. Sakane, and N. Suzuki Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus Clin Exp Rheumatol 21 2003 71 77
222. T. Tsubata, M. Murakami, S. Nisitani, and T. Honjo Molecular mechanisms for B lymphocyte selection: induction and regulation of antigen-receptor- mediated apoptosis of mature B cells in normal mice and their defect in autoimmunity-prone mice Philos Trans R Soc Lond B Biol Sci 345 1994 297 301
223. M. Neidhart Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion Biomed Pharmcother 51 1997 118 125
224. E. Peeva, C. Grimaldi, L. Spatz, and B. Diamond Bromocriptine restores tolerance in estrogen-treated mice J Clin Invest 106 2000 1373 1379
225. S.M. Viselli, K.R. Reese, J. Fan, W.J. Kovacs, and N.J. Olsen Androgens alter B cell development in normal male mice Cell Immunol 182 1997 99 104
226. N.J. Olsen, X. Gu, and W.J. Kovacs Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development J Clin Invest 108 2001 1697 1704
227. S.M. Viselli, S. Stanziale, K. Shults, W.J. Kovacs, and N.J. Olsen Castration alters peripheral immune function in normal male mice Immunology 84 1995 337 342
228. J.H. Cohen, L. Danel, G. Cordier, S. Saez, and J.P. Revillard Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells J Immunol 131 1983 2767 2771
229. S.E. Walker, C.L. Besch-Williford, and D.H. Keisler Accelerated deaths from systemic lupus erythematosus in NZB × NZW F1 mice treated with the testosterone-blocking drug flutamide J Lab Clin Med 124 1994 401 407
230. J.A. Lucas, S.A. Ahmed, M.L. Casey, and P.C. MacDonald Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone J Clin Invest 75 1985 2091 2093
231. S.D. Norton, L.L. Harrison, R. Yowell, and B.A. Araneo Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice Autoimmunity 26 1997 161 171
232. L.W. Keisler, A.B. Kier, and S.E. Walker Effects of prolonged administration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogesterone and ethinyl estradiol Autoimmunity 9 1991 21 32
233. R.G. Lahita, H.G. Kunkel, and H.L. Bradlow Increased oxidation of testosterone in systemic lupus erythematosus Arthritis Rheum 26 1983 1517 1521
234. D. Verthelyi, M. Petri, M. Ylamus, and D.M. Klinman Disassociation of sex hormone levels and cytokine production in SLE patients Lupus 10 2001 352 358
235. R.F. van Vollenhoven, J.L. Park, M.C. Genovese, J.P. West, and J.L. McGuire A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus Lupus 8 1999 181 187
236. M.A. Petri, R.G. Lahita, R.F. Van Vollenhoven, J.T. Merrill, M. Schiff, and E.M. Ginzler Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial Arthritis Rheum 46 2002 1820 1829
237. M.A. Petri, P.J. Mease, J.T. Merrill, R.G. Lahita, M.J. Iannini, and D.E. Yocum Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus Arthritis Rheum 50 2004 2858 2868
238. D.M. Chang, S.J. Chu, H.C. Chen, S.Y. Kuo, and J.H. Lai Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus Ann Rheum Dis 63 2004 1623 1626
239. N. Kanda, T. Tsuchida, and K. Tamaki Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus Arthritis Rheum 40 1997 1703 1711
240. S. Safe Environmental estrogens: roles in male reproductive tract problems and in breast cancer Rev Environ Health 17 2002 253 262
241. M. Joffe Infertility and environmental pollutants Br Med Bull 68 2003 47 70
242. S.A. Ahmed The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field Toxicology 150 2000 191 206
243. S.C. Polischuk, R.J. Letcher, R.J. Norstrom, and M.A. Ramsay Preliminary results of fasting on the kinetics of organochlorines in polar bears (Ursus maritimus) Sci Total Environ 160-161 1995 465 472
244. A.M. Soto, C. Sonnenschein, K.L. Chung, M.F. Fernandez, N. Olea, and F.O. Serrano The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants Environ Health Perspect 103 Suppl. 7 1995 113 122
245. A.M. Cummings, and L.E. Gray Jr. Antifertility effect of methoxychlor in female rats: dose- and time-dependent blockade of pregnancy Toxicol Appl Pharmacol 97 1989 454 462
246. D.M. Fry, and C.K. Toone DDT-induced feminization of gull embryos Science 213 1981 922 924
247. K.F. Arcaro, L. Yi, R.F. Seegal, D.D. Vakharia, Y. Yang, and D.C. Spink 2,2′,6,6′-Tetrachlorobiphenyl is estrogenic in vitro and in vivo J Cell Biochem 72 1999 94 102
248. F. Kohen, L. Abel, A. Sharp, Y. Amir-Zaltsman, D. Somjen, and S. Luria Estrogen-receptor expression and function in thymocytes in relation to gender and age Dev Immunol 5 1998 277 285
249. G. Blyler, K.S. Landreth, and J.B. Barnett Gender-specific effects of prenatal chlordane exposure on myeloid cell development Fundam Appl Toxicol 23 1994 188 193
250. D.W. Singleton, Y. Feng, Y. Chen, S.J. Busch, A.V. Lee, and A. Puga Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells Mol Cell Endocrinol 221 2004 47 55
251. T. Takao, W. Nanamiya, I. Nagano, K. Asaba, K. Kawabata, and K. Hashimoto Exposure with the environmental estrogen bisphenol A disrupts the male reproductive tract in young mice Life Sci 65 1999 2351 2357
252. T. Takeuchi, O. Tsutsumi, Y. Ikezuki, Y. Takai, and Y. Taketani Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction Endocr J 51 2004 165 169
253. J.C. Norman, P.T. Harrison, W. Davis, R.A. Floto, and J.M. Allen Lysosomal routing of Fc gamma RI from early endosomes requires recruitment of tyrosine kinases Immunology 94 1998 48 55
254. A. Hermanowicz, Z. Nawarska, D. Borys, and A. Maslankiewicz The neutrophil function and infectious diseases in workers occupationally exposed to organochloride insecticides Int Arch Occup Environ Health 50 1982 329 340
255. A.M. Rosenberg, K.M. Semchuk, H.H. McDuffie, D.L. Ledingham, D.M. Cordeiro, and A.J. Cessna Prevalence of antinuclear antibodies in a rural population J Toxicol Environ Health A 57 1999 225 236
256. H. Yurino, S. Ishikawa, T. Sato, K. Akadegawa, T. Ito, and S. Ueha Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells Toxicol Sci 81 2004 139 147
257. J.J. Stewart The female X-inactivation mosaic in systemic lupus erythematosus Immunol Today 19 1998 352 357
258. D.A. Sullivan Sex hormones and Sjogren's syndrome J Rheumatol Suppl 50 1997 17 32
259. P. Hasler, and M. Zouali B cell receptor signaling and autoimmunity FASEB J 15 2001 2085 2098
260. P. Hasler, and M. Zouali Subversion of B lymphocyte signaling by infectious agents Genes Immun 4 2003 95 103